Abstract
Hemoptysis is an alarming symptom which is distressing for patients and their families. Where possible it is best treated by addressing the underlying cause. Radiotherapy is usually effective in controlling hemoptysis from a bronchial carcinoma, for example. Massive hemoptysis is defined as >200 mls in 24 h. When a major vessel is eroded, bleeding may be catastrophic and rapidly fatal, and there is little to be done except to ensure that the patient is given medications such as benzodiazepines and opioids to relieve anxiety and breathlessness. If the patient survives, the initial bleed resuscitation is directed at maintaining the airway and circulatory volume. Most major bleeding arises from the bronchial arteries and bronchial artery embolization is usually effective in stopping bleeding by occluding the vascular supply.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Remy J, Remy-Jardin M, Voisin C. Endovascular management of bronchial bleeding. In: Butler J, editor. The bronchial circulation. New York: Dekker; 1992. p. 667–723.
Cauldwell EW, Siekert R, Liniger RE, Anson BJ. The bronchial arteries: an anatomic study of 105 human cadavers. Surg Gynecol Obstet. 1948;86:395–412.
Hirshberg B, Biven I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation and outcome in a tertiary referral hospital. Chest. 1997;112:440–4.
Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fibre optic bronchoscopy before bronchial artery embolisation for massive hemoptysis. Am J Roentgenol. 2001;177:861–7.
O’Driscoll BR, Howard LS, Davison AG, British Thoracic Society. BTS guideline for Âemergency oxygen use in adult patients. Thorax. 2008;63 Suppl 6:1–68.
Conlan AA, Hurwitz SS. Management of massive haemoptysis with rigid bronchoscopy and cold saline lavage. Thorax. 1980;35:901–4.
Hiebert CA. Balloon catheter control of life-threatening haemoptysis. Chest. 1974;66:308–9.
Saw EC, Gottlieb LS, Yokoyama T, Lee BC. Flexible fibreoptic bronchoscopy and endobronchial tamponade in the management of massive hemoptysis. Chest. 1976;70:589–91.
The Medical Research Council Lung Cancer Working Party. Inoperable non small cell lung cancer: a medical research council randomised trial of palliative radiotherapy with 2 fractions or 10 fractions. Br J Cancer. 1991;63:265–70.
Reinfuss M, Mucha-Malecka A, Walasek T. Palliative thoracic radiotherapy in non small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer. 2011;71:344–99.
Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2000;47:149–55.
Lester JF, Macbeth FR, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev. 2006;(4):CD002143.
Falkson C, Sur R, Pachella J. External beam radiotherapy: a treatment option for massive haemoptysis caused by mycetoma. Clin Oncol. 2002;14:233–5.
Gulliver S, Holt SG, Newman GH, Kingdon EJ. Radiotherapy for a pulmonary aspergilloma complicating p-ANCA positive small vessel vasculitis. J Infect. 2007;54:215–7.
Crossno PF, Loyd JE, Milstone AP. External-beam radiotherapy for massive hemoptysis Âcomplicating mediastinal fibrosis. South Med J. 2008;101:1056–8.
Cardona AF, Reveiz L, Ospina EG, Ospina V, Yepes A. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2008;(2):CD004284.
Ung YC, Yu E, Falkson C, Haynes AE, Stys-norman D, Evans WA, Lung cancer Disease Site Group of Cancer Care Ontario Program in Evidence-based care. The role of high dose rate brachytherapy in the palliation of symptoms in patients with non small cell lung cancer: a systematic review. Brachytherapy. 2006;5:189–202.
Hara R, Itami J, Aruga T, et al. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies. Cancer. 2001;92:2623–7.
Kubaszewska M, Skowronek J, Chichel A, Kanikowski M. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irradiated lung cancer. Neoplasma. 2008;55:239–45.
Han CC, Prasetyo D, Wright GM. Endobronchial palliation using Nd:Yag laser is associated with improved survival when combined with multi-modal adjuvant treatments. J Thorac Oncol. 2007;2:59–64.
Morice RC, Ece T, Ece F, Keus L. Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest. 2001;119:781–7.
Chun JY, Belli AM. Immediate and long term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis. Eur Radiol. 2010;20:558–65.
Dave BR, Sharma A, Kalva SP, Wicky S. Nine year single-center experience with transcatheter arterial embolisation for haemoptysis: medium-term outcomes. Vasc Endovascular Surg. 2011;45:258–68.
Daliri A, Probst NH, Jobst B, et al. Bronchial artery embolisation in patients with haemoptysis including follow up. Acta Radiol. 2011;52:143–7.
Yoo DH, Yoon CJ, Kang SG, Burke CT, Lee JH, Lee CT. Bronchial and non-bronchial systemic artery embolisation in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate. Am J Roentgenol. 2011;196:199–204.
van den Heuvel MM, Els Z, Koegelenberg CF, Naidu KM, Bolliger CT, Diacon AH. Risk Âfactors for recurrence of hemoptysis following bronchial artery embolisation for life threatening hemoptysis. Int J Tuberc Lung Dis. 2007;11:909–14.
Brinson GM, Noone PG, Mauro MA, et al. Bronchial artery embolisation for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med. 1998;157:1951–8.
Vidal V, Therasse E, Berthiaume Y, et al. Bronchial artery embolisation in adults with cystic fibrosis: impact on the clinical course and survival. J Vasc Interv Radiol. 2006;17:953–8.
Barben J, Robertson D, Olinsky A, Ditchfield M. Bronchial artery embolisation for haemoptysis in young patients with cystic fibrosis. Radiology. 2002;224:124–30.
Wang GR, Ensor J, Gupta S, Hicks ME, Tam AL. Bronchial artery embolisation for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 2009;20:722–9.
Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and a non bronchial systemic artery embolisation for life threatening hemoptysis: a comprehensive review. Radiographics. 2002;22:1395–409.
Tscheikuna J, Chvaychoo B, Naruman C, Maranetra N. Tranexamic acid in patients with hemoptysis. J Med Assoc Thai. 2002;85:399–404.
Graff GR. Treatment of recurrent severe haemoptysis in cystic fibrosis with tranexamic acid. Respiration. 2001;68:91–4.
Sung JJ, Lau JY, Ching JY, et al. Continuation of low dose aspirin therapy in peptic ulcer bleeding; a randomised trial. Ann Intern Med. 2010;152:1–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Higgins, B. (2013). Hemoptysis. In: Bourke, S., Peel, E. (eds) Integrated Palliative Care of Respiratory Disease. Springer, London. https://doi.org/10.1007/978-1-4471-2230-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2230-2_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2229-6
Online ISBN: 978-1-4471-2230-2
eBook Packages: MedicineMedicine (R0)